This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignees: Imperial College Innovations Limited, Myricx Pharma Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 173 
2 out of 2 Years Active: 2026
Title: Robin Carr - Innovator in Cytotoxic Compounds
Introduction
Robin Carr is a notable inventor based in London, GB. He has made significant contributions to the field of therapy through his innovative work on cytotoxic compounds. His dedication to research and development has led to the creation of a valuable patent.
Latest Patents
Robin Carr holds a patent for "Cytotoxic Imidazo[1,2-a]pyridine Compounds and Their Use in Therapy." This patent represents his commitment to advancing therapeutic options and improving patient outcomes.
Career Highlights
Throughout his career, Robin has worked with esteemed organizations such as Myricx Pharma Limited and Imperial College Innovations Limited. His experience in these companies has allowed him to refine his skills and contribute to groundbreaking research.
Collaborations
Robin has collaborated with talented individuals in his field, including Roberto Solari and Andrew Simon Bell. These partnerships have fostered innovation and have been instrumental in the development of his patented work.
Conclusion
Robin Carr's contributions to the field of therapy through his patent and collaborations highlight his role as an influential inventor. His work continues to inspire advancements in medical research and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile